Fidson to produce generic influenza drug, strengthen health security

AI Summary

Nigeria’s Fidson Healthcare has been selected to manufacture a generic version of Roche’s influenza medicine baloxavir marboxil. The drug is intended for supply to 129 countries, expanding access to influenza treatment and strengthening health security.

Fidson Healthcare Plc has been selected to manufacture a generic version of Roche’s influenza drug, baloxavir marboxil, for supply to 129 countries. Read More: https://punchng.com/fidson-to-produce-generic-influenza-drug-strengthen-health-security/